NOBEL BIOCARE NORGE AS • 987621354 • Moss • Wholesale trade, except of motor vehicles and motorcycles

This website uses cookies to enhance the user experience.

Goods and trade

/ Purchase and sale

/ 46.460 Wholesale of pharmaceutical goods

NOBEL BIOCARE NORGE AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: JJ
Jan Jerne1966
Chairman of the board: MK
Magnus Karl Andreas Pettersson1971
Years since formation: 21 years; since Dec 22, 2004
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 1,000; 1 share class
Total number of shareholders: 1; person
Belongs to group of

Financials

Total operating income 2023: 28,655,858; NOK
Annual total result 2023: -519,485; NOK
Total equity 2023: 8,276,169; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
JJ Jan Jerne 1966	Managing Director/CEO	-

Board

Name	Role	Shares
MK Magnus Karl Andreas Pettersson 1971	Chairman	-
HE Harrieth Eva Elisabeth Sundaeus 1956	Board Member	-
SF Stefan Fabian Lieb 1985	Board Member	-

Others

Name	Role	Shares
G GRANT THORNTON REVISJON AS	Auditor	-
A AZETS INSIGHT AS	Accountant	-
M MPR REGNSKAP AS	Accountant	-

Last update: Apr 10, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
BN Biocare Norden Ab Nobel	Ordinary shares	1,000	100 %

Shares owned by the NOBEL BIOCARE NORGE AS

Name	Share class	Total number of shares	Share
N NORORTHO AS	Ordinary shares	200	100 %

Last update: May 24, 2024

Group structure

NOBEL BIOCARE NORGE AS
Total operating income 2023: NOK 28,655,858
Operating profit 2023: NOK 293,404
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	28,655,858	32,429,088	34,083,491
Annual Total Result	-519,485	92,721	1,156,886
Total assets	30,380,684	29,940,260	30,124,875
Total liabilities	22,104,516	21,144,607	21,421,943
Total equity	8,276,169	8,795,653	8,702,932

P&L

Year	2023	2022	2021
Total operating income	28,655,858	32,429,088	34,083,491
Total operating costs	28,362,453	31,861,102	32,406,472
Operating result	293,404	567,987	1,677,019
Financial income/costs	-958,194	-441,516	-193,003
Profit before tax	-664,789	126,471	1,484,016
Total tax & extraordinary income/cost	-145,304	33,750	327,130
Annual Total Result	-519,485	92,721	1,156,886

Balance overview

Year	2023	2022	2021
Total fixed assets	18,665,290	18,519,986	18,425,543
Total current assets	11,715,394	11,420,274	11,699,332
Total assets	30,380,684	29,940,260	30,124,875
Short term debt	22,104,516	21,144,607	21,421,943
Long term debt	0	0	0
Total liabilities	22,104,516	21,144,607	21,421,943
Contributed capital	100,000	100,000	100,000
Retained earnings	8,176,169	8,695,653	8,602,932
Total equity	8,276,169	8,795,653	8,702,932
Total equity and liabilities	30,380,684	29,940,260	30,124,875

Classification

Category

Goods and trade

/ Purchase and sale

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

G

Main industrial area

Wholesale and retail trade; repair of motor vehicles and motorcycles

46

Activity

Wholesale trade, except of motor vehicles and motorcycles

46.4

Main industrial group

Wholesale of household goods

46.46

Industrial group

Wholesale of pharmaceutical goods

46.460

Industrial group

Wholesale of pharmaceutical goods